Given the wide use of these drugs, these adverse events, although rare, must be considered by patients thinking about using them for weight loss, said first author Mohit Sodhi, a graduate of UBCs experimental medicine program and fourth-year UBC medical student studying the adverse events of commonly prescribed medications
PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights, including GIPR variants that affect tirzepatide sensitivity
What sits on the other side of that gap is decades of animal studies showing consistent effects across tissue repair, inflammation, neurological function, and metabolic health
Clinical trials show Semaglutide can produce meaningful weight loss: on average about 15% of starting body weight after roughly 68 weeks of treatment
Hypothalamus In the catalase activity assay (Fig
Clinical trials have demonstrated that tirzepatide injections can lead to significant weight loss, with participants losing an average of 15 to 20 percent of their body weight over 72 weeks